{"SPADE_UN_19045": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_19045", "Peptide Name": "RNST-2-14K (RSP-1, Synthetic AMPs, XXD, XXA, UCLL1c)", "Source": "sequence extension, designed, man-made sequences", "Family": "Not found", "Gene": "Not found", "Sequence": "FLKGLMGVIASLFK", "Sequence Length": 14, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Antifungal", "Anti-MRSA", "Hemolytic", "Anticancer"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 1523.92, "PI": 10.0, "Hydrophobicity": 1.43, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Abdullah SJ, Guan JS, Mu Y, Bhattacharjya S.2024", "Reference": "Antibiotics (Basel). 2024 Dec 13;13(12):1213. doi: 10.3390/antibiotics13121213.PubMed", "Title": "Synthesis of Temporin-SHa Retro Analogs with Lysine Addition/Substitution and Antibiotic Conjugation to Enhance Antibacterial, Antifungal, and Anticancer Activities."}], "Frequent Amino Acids": "LFG", "Absent Amino Acids": "CDEHNOPQRTUWY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 5, "Positive Residues": 2, "Negative Residues": 0, "Net Charge": 2, "Comments": "Sequence analysis: APD analysis reveals that this sequence is unique and shows only very low similarity (60%) toLausporin-1L:21%, G=K=F:Chemical modification: A10: D-amino acid; C-terminal amidation.Activity: active against Gram+ S. aureus NCTC 13277 MRSA (MIC 6.25 uM), B. subtilis ATCC 23857 (MIC 1.56 uM), Gram- S. typhi ATCC 14028 (MIC 50 uM), E. coli ATCC 25922 (MIC 25 uM), P. aeruginosa ATCC 10145 (MIC 50 uM), and fungi C. albicans ATCC 36082 (MIC 15.6 uM).Structure:  helical in 20 mM SDS.In vitro toxicity: human RBC: HC50 51 uM. Hemolytic. Breast cancer cells MCF-7 (IC50 42.7 uM), cervical cancer Hela cells (IC50 33.5 uM).", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_17517", "Similarity": 1.0, "Sequence": "IFGTILGFLKGL"}, {"SPADE_ID": "SPADE_UN_19043", "Similarity": 1.0, "Sequence": "FLKGLMGVIASLF"}, {"SPADE_ID": "SPADE_UN_18314", "Similarity": 1.0, "Sequence": "SLFKDQMEL"}]}}}